Pulmonx LUNG
NASDAQ LUNG
$2.32 +0.01 (+0.22%)
At close: Aug 20, 2026 · 1:04 PM UTC

Pulmonx (LUNG) EBIT Margin (2019 - 2025)

Pulmonx (LUNG) posted quarterly EBIT Margin of 66.94% for Q3 2025, up 237.0% year-over-year from 19.86% in Q3 2024, and down 7.88% quarter-over-quarter from 62.05% in Q2 2025.

Pulmonx (LUNG) EBIT Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has reported EBIT Margin for 7 consecutive years, with 66.94% the latest figure, recorded in Q3 2025.

  • In Q3 2025, EBIT Margin rose 237.0% year-over-year to 66.94%; the TTM figure through Sep 2025 stood at 62.38% (up 1102.0% YoY), while the FY2024 annual figure was 68.87%, up 2132.0% from the prior year.
  • EBIT Margin declined to 66.94% in Q3 2025 per LUNG's latest filing, from 62.05% in the prior quarter.
  • Across five years, EBIT Margin topped out at 56.46% in Q4 2024 and bottomed at 145.28% in Q1 2022.
  • Historically, EBIT Margin has averaged 88.82% across 5 years, with a median of 85.9% in 2023.
  • On a YoY basis, EBIT Margin climbed as much as 20988 bps in 2021 and fell as far as 6433 bps in 2021.
  • Pulmonx's EBIT Margin stood at 90.21% in 2021, then dropped by 5 bps to 94.83% in 2022, then advanced by 24 bps to 72.2% in 2023, then grew by 22 bps to 56.46% in 2024, then slipped by 19 bps to 66.94% in 2025.
  • Business Quant data shows LUNG's EBIT Margin at 66.94% in Q3 2025, 62.05% in Q2 2025, and 64.62% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 13.44%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 25.18%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 19.10%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 21.65%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 29.48%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 24.33%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 13.96%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 10.30%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 19.15%
10 Pulmonx 94.77 Mn 25.02 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -66.94%
Jun 30, 2025 -62.05%
Mar 31, 2025 -64.62%
Dec 31, 2024 -56.46%
Sep 30, 2024 -69.30%
Jun 30, 2024 -75.17%
Mar 31, 2024 -77.10%
Dec 31, 2023 -72.20%
Sep 30, 2023 -85.90%
Jun 30, 2023 -95.61%
Mar 31, 2023 -112.83%
Dec 31, 2022 -94.83%
Sep 30, 2022 -103.18%
Jun 30, 2022 -103.30%
Mar 31, 2022 -145.28%
Dec 31, 2021 -90.21%
Sep 30, 2021 -73.61%
Jun 30, 2021 -103.93%
Mar 31, 2021 -135.16%
Dec 31, 2020 -95.16%